Agios Pharmaceuticals Inc (STU:8AP)
€ 34.2 -3 (-8.06%) Market Cap: 1.93 Bil Enterprise Value: 1.03 Bil PE Ratio: 3.01 PB Ratio: 1.20 GF Score: 50/100

Agios Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Jan 13, 2020 / 03:30PM GMT
Release Date Price: €42.99 (-4.68%)
Anupam Rama
JP Morgan Chase & Co, Research Division - VP and Analyst

Okay. We'll go ahead and get started. I want to welcome everyone to the 2020 JPMorgan Health Care Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. Tessa Romero and Matt Bannon from the team are here as well. We're kicking off the conference with Agios, and presenting on behalf of the company is CEO, Jackie Fouse. Jackie?

Jacqualyn A. Fouse
Agios Pharmaceuticals, Inc. - CEO & Director

Thank you, Anupam. Good morning, everybody. Thanks for -- happy New Year, first of all. Thanks for joining us this morning. We're quite honored to kick off this presentation stream for the 2020 JPM meeting this year.

And we're pretty excited about where we are as a company. After being around for 10-plus years, we see some clear inflection points coming for us in terms of where we can take our science and we look forward to sharing that with you today. That's why we want to put some stakes in the ground around our 2025 vision, and we'll also talk

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot